Contralateral prophylactic mastectomy: Mind the genetics

Journal of Clinical Oncology

Volumn 26, Issue 11, 2008, Pages 1909-1910

  Briasoulis, Evangelos ^a   Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ANAMNESIS; BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; GENE MUTATION; GENETIC COUNSELING; HEALTH CARE SYSTEM; HEREDITY; HOSPITAL PHYSICIAN; HUMAN; LETTER; MASTECTOMY; MEDICAL DECISION MAKING; MEDICAL SOCIETY; OVARIECTOMY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; ADOLESCENT; ADULT; AGED; BREAST TUMOR; CANCER REGISTRY; FEMALE; GENETIC SCREENING; GENETICS; METHODOLOGY; MIDDLE AGED; NOTE; SECOND CANCER;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SEER PROGRAM;

EID: 42949139953     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.0275     Document Type: Letter

References (15)

1. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007
2. Hislop TG, Elwood JM, Coldman AJ, et al: Second primary cancers of the breast: Incidence and risk factors. Br J Cancer 49:79-85, 1984
3. Leis HP: Selective, elective, prophylactic contralateral mastectomy. Cancer 28:956-961, 1971
4. Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84, 1999
5. Herrinton LJ, Barlow WE, Yu O, et al: Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. J Clin Oncol 23:4275-4286, 2005
6. Pierce LJ, Levin AM, Rebbeck TR, et al: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 24:2437-2443, 2006
7. van Sprundel TC, Schmidt MK, Rookus MA, et al: Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 93:287-292, 2005
8. Roukos DH, Briasoulis E: Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Nat Clin Pract Oncol 4:578-590, 2007
9. Roukos DH: Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357:1555-1556, 2007; author reply 1556
10. Nekhlyudov L, Bower M, Herrinton LJ, et al: Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr 35:55-60, 2005
11. Rolnick SJ, Altschuler A, Nekhlyudov L, et al: What women wish they knew before prophylactic mastectomy. Cancer Nurs 30:285-291, 2007
12. Roukos DH: Innovative genomic-based model for personalized treatment of gastric cancer: Integrating current standards and new technologies. Expert Rev Mol Diagn 8:29-39, 2008
13. Roukos DH, Murray S, Briasoulis E: Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6:308-312, 2007
14. Fatouros M, Baltoyiannis G, Roukos DH: The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15:21-33, 2008
15. Robson M, Offit K: Management of an inherited predisposition to breast cancer. N Engl J Med 357:154-162, 2007